References
- Townsend N , WilsonL, BhatnagarP, WickramasingheK, RaynerM, NicholsM. Cardiovascular disease in Europe: epidemiological update 2016. Eur. Heart J.37(42), 3232–3245 (2016).
- Guo Y , LuoF, LiuQ, XuD. Regulatory non-coding RNAs in acute myocardial infarction. J. Cell. Mol. Med.21(5), 1013–1023 (2017).
- Varda-Bloom N , LeorJ, OhadDGet al. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J. Mol. Cell. Cardiol.32(12), 2141–2149 (2000).
- Balkow S , KerstenA, TranTTTet al. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J. Virol.75(18), 8781–8791 (2001).
- Hiebert PR , BoivinWA, ZhaoH, McManusBM, GranvilleDJ. Perforin and granzyme B have separate and distinct roles during atherosclerotic plaque development in apolipoprotein E knockout mice. PLoS ONE8(10), e78939 (2013).
- Fan Z , ZhangQ. Molecular mechanisms of lymphocyte-mediated cytotoxicity. Cell. Mol. Immunol.2(4), 259–264 (2005).
- Oztas E , OzlerS, TokmakAet al. Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients. Eur. J. Obstet. Gynecol. Reprod. Biol.198, 89–93 (2016).
- Chamberlain CM , AngLS, BoivinWAet al. Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm. Am. J. Pathol.176(2), 1038–1049 (2010).
- Kondo H , HojoY, TsuruRet al. Elevation of plasma granzyme B levels after acute myocardial infarction. Circ. J.73(3), 503–507 (2009).
- El-Mesallamy HO , HamdyNM, El-EtribyAKet al. Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine. Mediators Inflamm. 2013, 343268 (2013).
- Fiedler J , ThumT. MicroRNAs in myocardial infarction. Arterioscler. Thromb. Vasc. Biol.33(2), 201–205 (2013).
- Sun H , CaiJ, XuLet al. Expression of miR-21 is involved in myocardial infarction through the IL-6/STAT3 and Bcl-2/caspase-3 pathway. Int. J. Clin. Exp. Pathol.9(3), 2795–2802 (2016).
- Schulte C , ZellerT. microRNA-based diagnostics and therapy in cardiovascular disease-summing up the facts. Cardiovasc. Diagn. Ther.5(1), 17–36 (2015).
- Chan D , NgLL. Biomarkers in acute myocardial infarction. BMC Med.8(1), 34 (2010).
- Sourvinou IS , MarkouA, LianidouES. Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability. J. Mol. Diagn.15(6), 827–834 (2013).
- Saito Y , KondoH, HojoY. Granzyme B as a novel factor involved in cardiovascular diseases. J. Cardiol.57(2), 141–147 (2011).
- Mittal M , SiddiquiMR, TranK, ReddySP, MalikAB. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal.20(7), 1126–1167 (2014).
- Jacquemin G , MargiottaD, KasaharaAet al. Granzyme B-induced mitochondrial ROS are required for apoptosis. Cell Death Differ.22(5), 862–874 (2015).
- Wang K , LiuF, ZhouLYet al. miR-874 regulates myocardial necrosis by targeting caspase-8. Cell Death Dis.4(7), e709 (2013).
- Bhela S , KempsellC, ManoharMet al. Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR– CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J. Immunol.194(5), 2180–2189 (2015).
- Ives ML , MaCS, PalendiraUet al. STAT3 mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8+ T cell memory formation and function. J. Allergy Clin. Immunol.132(2), 400 (2013).
- Puri KS , SureshKR, GogtayNJ, ThatteUM. Declaration of Helsinki, 2008: implications for stakeholders in research. J. Postgrad. Med.55(2), 131 (2009).